{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:16:52Z","timestamp":1781306212807,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Novel effective anti-influenza agent that tolerates influenza virus antigenic variation is needed. Highly conserved influenza virus M2 protein has multiple pivotal functions including ion channel activity for vRNP uncoating, anti-autophagy and virus assembly, morphogenesis and release. Thus, M2 is an attractive target of anti-influenza agents including small molecular drugs and specific antibodies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Fully human monoclonal single chain antibodies (HuScFv) specific to recombinant and native M2 proteins of A\/H5N1 virus were produced from<jats:italic>huscfv<\/jats:italic>-phagemid transformed<jats:italic>E. coli<\/jats:italic>clones selected from a HuScFv phage display library using recombinant M2 of clade 1 A\/H5N1 as panning antigen. The HuScFv were tested for their ability to inhibit replication of A\/H5N1 of both homologous and heterologous clades. M2 domains bound by HuScFv of individual<jats:italic>E. coli<\/jats:italic>clones were identified by phage mimotope searching and computerized molecular docking.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>HuScFv derived from four<jats:italic>huscfv<\/jats:italic>-phagemid transformed<jats:italic>E. coli<\/jats:italic>clones (no. 2, 19, 23 and 27) showed different amino acid sequences particularly at the CDRs. Cells infected with A\/H5N1 influenza viruses (both adamantane sensitive and resistant) that had been exposed to the HuScFv had reduced virus release and intracellular virus. Phage peptide mimotope search and multiple alignments revealed that conformational epitopes of HuScFv2 located at the residues important for ion channel activity, anti-autophagy and M1 binding; epitopic residues of HuScFv19 located at the M2 amphipathic helix and cytoplasmic tail important for anti-autophagy, virus assembly, morphogenesis and release; epitope of HuScFv23 involved residues important for the M2 activities similar to HuScFv2 and also amphipathic helix residues for viral budding and release while HuScFv27 epitope spanned ectodomain, ion channel and anti-autophagy residues. Results of computerized homology modelling and molecular docking conformed to the epitope identification by phages.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HuScFv that bound to highly conserved epitopes across influenza A subtypes and human pathogenic H5N1clades located on different functional domains of M2 were produced. The HuScFv reduced viral release and intracellular virus of infected cells. While the molecular mechanisms of the HuScFv await experimental validation, the small human antibody fragments have high potential for developing further as a safe, novel and mutation tolerable anti-influenza agent especially against drug resistant variants.<\/jats:p><\/jats:sec>","DOI":"10.1186\/1743-422x-10-148","type":"journal-article","created":{"date-parts":[[2013,5,14]],"date-time":"2013-05-14T22:14:17Z","timestamp":1368569657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Human monoclonal ScFv that bind to different functional domains of M2 and inhibit H5N1 influenza virus replication"],"prefix":"10.1186","volume":"10","author":[{"given":"Tippawan","family":"Pissawong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santi","family":"Maneewatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanyarat","family":"Thueng-in","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Potjanee","family":"Srimanote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fonthip","family":"Dong-din-on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeraphong","family":"Thanongsaksrikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaweesak","family":"Songserm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongsri","family":"Tongtawe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunan","family":"Bangphoomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanpen","family":"Chaicumpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,14]]},"reference":[{"key":"2137_CR1","first-page":"563","volume":"10","author":"LJ Nieva","year":"2012","unstructured":"Nieva LJ, Madan V, Carrasco L: Viroporins: structure and biological functions. Nature Review. 2012, 10: 563-574.","journal-title":"Nature Review"},{"key":"2137_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/nature06531","volume":"451","author":"JR Schnell","year":"2008","unstructured":"Schnell JR, Chou JJ: Structure and mechanism of the M2 proton channel of influenza A virus. Nature. 2008, 451: 591-595.","journal-title":"Nature"},{"issue":"2","key":"2137_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","volume":"411","author":"SJ Rossman","year":"2011","unstructured":"Rossman SJ, Lamb AR: Influenza virus assembly and budding. Virology. 2011, 411 (2): 229-236.","journal-title":"Virology"},{"issue":"3","key":"2137_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","volume":"40","author":"AR Lamb","year":"1985","unstructured":"Lamb AR, Zebedee LS, Richard DC: Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface. Cell. 1985, 40 (3): 627-633.","journal-title":"Cell"},{"issue":"8","key":"2137_CR5","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/jvi.62.8.2762-2772.1988","volume":"62","author":"LS Zebedee","year":"1988","unstructured":"Zebedee LS, Lamb AR, Influenza A virus M2 protein: Monoclonal antibody restriction of virus growth and detection of M2 in virion. J Virol. 1988, 62 (8): 2762-2772.","journal-title":"J Virol"},{"key":"2137_CR6","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/0092-8674(92)90219-3","volume":"69","author":"A Helenius","year":"1992","unstructured":"Helenius A: Unpacking the incoming influenza virus. Cell. 1992, 69: 577-578.","journal-title":"Cell"},{"key":"2137_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0042-6822(92)90730-D","volume":"188","author":"F Ciampor","year":"1992","unstructured":"Ciampor F, Bayley MP, Nermut VM, Hirst AME, Sugrue JR, Hay JA: Evidence that the amantadine-induced, M2-mediated conversion of influenza A virus hemagglutinin to the low pH conformation occurs in an acid trans golgi compartment. Virology. 1992, 188: 14-24.","journal-title":"Virology"},{"key":"2137_CR8","first-page":"367","volume":"6","author":"M Gannage","year":"2009","unstructured":"Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T: Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysomes. Cell. 2009, 6: 367-380.","journal-title":"Cell"},{"issue":"RR01","key":"2137_CR9","first-page":"1","volume":"60","author":"EA Fiore","year":"2011","unstructured":"Fiore EA, Fry A, Shay D, Gubareva L, Bresee SJ, Uyeki MT: Antiviral agents for the treatment and chemoprophylaxis of influenza. MMWR. 2011, 60 (RR01): 1-24.","journal-title":"MMWR"},{"key":"2137_CR10","first-page":"1","volume":"10","author":"T Jefferson","year":"2012","unstructured":"Jefferson T, Jones MA, Doshi P, Del Mar CB, Henegham CJ: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children (Review). The Cochrane library. 2012, 10: 1-224.","journal-title":"The Cochrane library"},{"issue":"1","key":"2137_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/infdis\/jiq005","volume":"203","author":"GT Sheu","year":"2011","unstructured":"Sheu GT, Fry MA, Garten JR, Deyde MV, Shine T, Bullion L: Dual resistance to amantadine and oseltamivir among seasonal influenza A (H1N1) viruses: 2008\u20132010. J Infect Dis. 2011, 203 (1): 13-17.","journal-title":"J Infect Dis"},{"key":"2137_CR12","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1056\/NEJM198209023071002","volume":"307","author":"R Dolin","year":"1982","unstructured":"Dolin R, Reichman CR, Madore PH, Maynard R, Linton NP, Webber-Jones J: A controlled trial of amantadine and rimantadine in the prophylaxis of influenza a infection. N Engl J Med. 1982, 307: 580-584.","journal-title":"N Engl J Med"},{"key":"2137_CR13","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1007\/s007050070088","volume":"145","author":"AV Smirnov","year":"2000","unstructured":"Smirnov AV, Lipatov SA, Gitelman KA, Class JE, Osehuas EA: Prevention and treatment of bronchopneumonia in mice caused by mouse-adapted variant of avian H5N2 influenza A virus using monoclonal antibody against conserved epitope in the HA stem region. Arch Virol. 2000, 145: 1733-1741.","journal-title":"Arch Virol"},{"key":"2137_CR14","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","volume":"173","author":"BK Renegar","year":"2004","unstructured":"Renegar BK, Small AP, Boykins GL, Wright FP: Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol. 2004, 173: 1978-1986.","journal-title":"J Immunol"},{"issue":"5","key":"2137_CR15","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1371\/journal.pmed.0040178","volume":"4","author":"PC Simmons","year":"2007","unstructured":"Simmons PC, Bernasconi LN, Suguitan LA, Mills K, Ward MJ, Chau VN: Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med. 2007, 4 (5): e178-","journal-title":"PLoS Med"},{"issue":"8","key":"2137_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","volume":"145","author":"TC Luke","year":"2006","unstructured":"Luke TC, Kilbane EM, Jackson JL, Hoffman SL: Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?. Ann Intern Med. 2006, 145 (8): 599-609.","journal-title":"Ann Intern Med"},{"issue":"14","key":"2137_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMc070359","volume":"357","author":"B Zhou","year":"2007","unstructured":"Zhou B, Zhong N, Guan Y: Treatmant with convalescent plasma for influenza A (H5N1) infection. N Engl J Med. 2007, 357 (14): 1450-1451.","journal-title":"N Engl J Med"},{"key":"2137_CR18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/135965350901400204","volume":"14","author":"S Maneewatch","year":"2009","unstructured":"Maneewatch S, Thanongsaksrikul J, Songserm T, Thueng-In K, Kulkeaw K: Human single-chain antibodies that neutralize homologous and heterologous strains and clades of influenza A virus. Antivir Ther. 2009, 14: 221-223.","journal-title":"Antivir Ther"},{"issue":"3","key":"2137_CR19","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/jvi.64.3.1375-1377.1990","volume":"64","author":"JJ Treanor","year":"1990","unstructured":"Treanor JJ, Tierney LE, Zebedee LS, Lamb AR, Murphy RB: Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice. J Virol. 1990, 64 (3): 1375-1377.","journal-title":"J Virol"},{"key":"2137_CR20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00595-003-2710-4","volume":"34","author":"R Kim","year":"2004","unstructured":"Kim R, Toge T: Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents. Surg Today. 2004, 34: 293-303.","journal-title":"Surg Today"},{"key":"2137_CR21","doi-asserted-by":"publisher","first-page":"6765","DOI":"10.1016\/j.vaccine.2010.07.065","volume":"28","author":"K Theug-in","year":"2010","unstructured":"Theug-in K, Maneewatch S, Srimanote P, Songserm T, Tapchaisri P: Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines. Vaccines. 2010, 28: 6765-6777.","journal-title":"Vaccines"},{"issue":"6003","key":"2137_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1126\/science.1191750","volume":"330","author":"M Sharma","year":"2010","unstructured":"Sharma M, Yi M, Dong H, Qin H, Peterson E: Insight into the mechanism of the influenza A proton channel from a structure in a lipid bilayer. Science. 2010, 330 (6003): 509-512.","journal-title":"Science"},{"issue":"34","key":"2137_CR23","doi-asserted-by":"publisher","first-page":"15075","DOI":"10.1073\/pnas.1007071107","volume":"107","author":"R Achaya","year":"2010","unstructured":"Achaya R, Carnevale V, Fiorin G, Levine BG, Polishchuk AL: Structure and mechanism of proton transport through the transmembrane tetrameric M2 protein bundle of the influenza A virus. Proc Natl Acad Sci. 2010, 107 (34): 15075-15080.","journal-title":"Proc Natl Acad Sci"},{"key":"2137_CR24","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/nature06528","volume":"451","author":"LA Stouffer","year":"2008","unstructured":"Stouffer LA, Acharya R, Salom A, Levine SA, Costanzo L: Structural basis for the function and inhibition of an influenza virus proton channel. Nature. 2008, 451: 596-599.","journal-title":"Nature"},{"issue":"5921","key":"2137_CR25","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1126\/science.323.5921.1560","volume":"323","author":"PS Layne","year":"2009","unstructured":"Layne PS, Monto SA, Taubenberger KS: Pandemic influenza: an inconvenient mutation. Science. 2009, 323 (5921): 1560-1561.","journal-title":"Science"},{"issue":"2","key":"2137_CR26","doi-asserted-by":"publisher","first-page":"e55271","DOI":"10.1371\/journal.pone.0055271","volume":"8","author":"DA Balgi","year":"2013","unstructured":"Balgi DA, Wang J, Cheng YHD, Ma C, Pfeifer AT: Inhibitors of the influenza A virus M2 ion channel discovered using a high-throughput yeast growth restoration assay. PLoS One. 2013, 8 (2): e55271-","journal-title":"PLoS One"},{"key":"2137_CR27","doi-asserted-by":"publisher","first-page":"7379","DOI":"10.1073\/pnas.0902548106","volume":"18","author":"MR Pielak","year":"2009","unstructured":"Pielak MR, Schnell RJ, Chou JJ: Mechanism of drug inhibition and drug resistance of influenza A M2 channel. Proc Natl Acad Sci. 2009, 18: 7379-7384.","journal-title":"Proc Natl Acad Sci"},{"issue":"50","key":"2137_CR28","doi-asserted-by":"publisher","first-page":"11872","DOI":"10.1021\/bi9014488","volume":"48","author":"V Balannik","year":"2009","unstructured":"Balannik V, Wang J, Ohigashi Y, Jing X, Magavern E: Design and pharmacological characterization of inhibitors of amantadine-resistant mutants of the M2 ion channel of influenza A virus. Biochemistry. 2009, 48 (50): 11872-11882.","journal-title":"Biochemistry"},{"key":"2137_CR29","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.drudis.2012.06.002","volume":"17","author":"J Du","year":"2012","unstructured":"Du J, Cross AT, Zhou HX: Recent progress in structure-based anti-influenza drug design. Drug Discov Today. 2012, 17: 1111-1120.","journal-title":"Drug Discov Today"},{"key":"2137_CR30","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0065-3527(08)60058-5","volume":"45","author":"L Carrasco","year":"1995","unstructured":"Carrasco L: Modification of membrane permeability by animal viruses. Adv Virus Res. 1995, 45: 61-112.","journal-title":"Adv Virus Res"},{"key":"2137_CR31","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/S0014-5793(03)00780-4","volume":"552","author":"ME Gonzalez","year":"2003","unstructured":"Gonzalez ME, Carrasco L: Viroporins. FEBS Lett. 2003, 552: 28-34.","journal-title":"FEBS Lett"},{"key":"2137_CR32","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/1570162043351246","volume":"2","author":"SD Hout","year":"2004","unstructured":"Hout SD: Vpu: A multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1. Curr HIV Res. 2004, 2: 255-270.","journal-title":"Curr HIV Res"},{"key":"2137_CR33","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.sbi.2010.12.002","volume":"21","author":"J Wang","year":"2011","unstructured":"Wang J, Qui JX, Soto C, DeGrado WF: Structural and dynamic mechanisms for the function and inhibition of the M2 proton channel from influenza A virus. Curr Opin Struct Biol. 2011, 21: 68-80.","journal-title":"Curr Opin Struct Biol"},{"key":"2137_CR34","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1038\/272694a0","volume":"272","author":"L Carrasco","year":"1978","unstructured":"Carrasco L: Membrane leakiness after viral infection and a new approach to the development of antiviral agents. Nature. 1978, 272: 694-699.","journal-title":"Nature"},{"issue":"11","key":"2137_CR35","doi-asserted-by":"publisher","first-page":"e49254","DOI":"10.1371\/journal.pone.0049254","volume":"7","author":"K Thueng-in","year":"2012","unstructured":"Thueng-in K, Thanongsaksrikul J, Srimanote P, Bangphoomi K, Pougpair O: Cell penetrable humanized-VH-VHH that inhibit RNA dependent RNA polymerase (NS5B) of HCV. PLoS One. 2012, 7 (11): e49254-","journal-title":"PLoS One"},{"key":"2137_CR36","volume-title":"WHO Manual on Animal Influenza Diagnosis and Surveillance. Department of Communicable Disease Surveillance and Response","author":"World Health Organization","year":"2002","unstructured":"World Health Organization: WHO Manual on Animal Influenza Diagnosis and Surveillance. Department of Communicable Disease Surveillance and Response. 2002, http:\/\/www.who.int\/vaccine_research\/diseases\/influenza\/WHO_manual_on_animal-diagnosis_and_surveillance_2002_5.pdf,"},{"key":"2137_CR37","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1099\/vir.0.012526-0","volume":"90","author":"JI Groves","year":"2009","unstructured":"Groves JI, Reeves BM, Sinclair HJ: Lytic infection of permissive cells with human cytomegalovirus is regulated by an intrinsic \u2018pre-immediated-early\u2019 repression of viral gene expression mediated by histone post-translational modification. J Gen Virol. 2009, 90: 2364-2374.","journal-title":"J Gen Virol"},{"issue":"4","key":"2137_CR38","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3201\/eid1204.051614","volume":"12","author":"T Songserm","year":"2006","unstructured":"Songserm T, Jam-on R, Sae-Heng N, Meesak N, Meemak N, Hulse-Past D: Domestic ducks and H5N1 influenza epidemic Thailand. Emerg Infect Dis. 2006, 12 (4): 575-581.","journal-title":"Emerg Infect Dis"},{"key":"2137_CR39","first-page":"1934","volume":"7","author":"EJ Coligan","year":"2012","unstructured":"Coligan EJ, Kruisbeek MA, Margulies HD, Shevach ME, Strober W: Current protocols in immunology. Wiley. 2012, 7: 1934-3671.","journal-title":"Wiley"},{"key":"2137_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.jprot.2008.12.007","volume":"72","author":"K Kulkeaw","year":"2009","unstructured":"Kulkeaw K, Sakolvaree Y, Srimanote P, Tongtawe P, Maneewatch S: Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaothia, neurotoxin. J Proteomics. 2009, 72: 270-282.","journal-title":"J Proteomics"},{"issue":"1","key":"2137_CR41","first-page":"23","volume":"26","author":"U Thathaisong","year":"2008","unstructured":"Thathaisong U, Maneewatch S, Kulkeaw K, Thueng-In K, Poungpair O, Srimanote P: Human monoclonal single chain antibodies (HuScFv) that bind to the polymerase proteins of influenza a virus. Asian Pac J Allergy Immunol. 2008, 26 (1): 23-35.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"2137_CR42","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1128\/JCM.37.4.937-943.1999","volume":"37","author":"T Rowe","year":"1999","unstructured":"Rowe T, Abernathy RA, Hu-Primmer J: Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999, 37: 937-443.","journal-title":"J Clin Microbiol"},{"key":"2137_CR43","unstructured":"EMBL-EBT Home page: EBI Tools: Clustaw2-Phylogeny. http:\/\/www.ebi.ac.uk\/Tools\/phylogeny\/clustaw2_phylogeny,"},{"key":"2137_CR44","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1107\/S0021889892009944","volume":"26","author":"RA Laskowski","year":"1993","unstructured":"Laskowski RA, MacArthur MW, Moss DS, Thornton JM: PROCHECK: a PROgram to CHECK the stereochemical quality of protein structures. J Appl Crystallogr. 1993, 26: 283-291.","journal-title":"J Appl Crystallogr"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1743-422X-10-148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T19:04:00Z","timestamp":1688238240000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/1743-422X-10-148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,14]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["2137"],"URL":"https:\/\/doi.org\/10.1186\/1743-422x-10-148","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,14]]},"assertion":[{"value":"13 February 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"148"}}